Viewing Study NCT03832361


Ignite Creation Date: 2025-12-24 @ 12:04 PM
Ignite Modification Date: 2025-12-24 @ 12:04 PM
Study NCT ID: NCT03832361
Status: RECRUITING
Last Update Posted: 2025-07-18
First Post: 2019-02-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer
Sponsor: Alessandro Santin
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module